
Antoni Ribas
researcherMale0.0Global Dominance: 0.00%
Antoni Ribas is a renowned oncologist and researcher at the Vall d’Hebron Institute of Oncology in Barcelona, Spain. He played a significant role in the early clinical trials of Keytruda, contributing to its development and approval as a revolutionary treatment for advanced melanoma and other cancers.
Power0
Reach0
Collect
Not in the pool (under ¢1).
Recent news mentions
Antoni Ribas played a key role in the early phases of the development of pembrolizumab.
Keytruda: el medicamento que factura tanto como Zara y genera debate sobre la duración de las patentes | SociedadEl País·
Spain· 2025-04-02





